Cocrystal Pharma Receives NIH SBIR Award to Advance its Influenza Inhibitor Program JornalWebDigital27.10.25BOTHELL, Wash., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc . (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces it has r...Leia Mais